The Director of the Agence nationale de sécurité du médicament et des produits de santé may ask the applicant for any additional information required to examine the application. The request for additional information sets the time limit within which the Etablissement Français du Sang or the Armed Forces Blood Transfusion Centre must respond. The three-month period provided for an application for approval or modification of approval is suspended until receipt of the information requested.
The Director General may make approval or modification of approval subject to an inspection carried out by the Agence nationale de sécurité du médicament et des produits de santé to ensure that the activities of a blood establishment, the Etablissement français du sang or the centre de transfusion sanguine des armées comply with the good practices referred to in Article L. 1222-12 and that the operating and equipment standards for blood establishments and the centre de transfusion sanguine des armées set out in this section are complied with.